Bausch Health Co. Inc. (NYSE: BHC) reported Q4 EPS of $1.15, $0.12 better than the analyst estimate of $1.03. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.29 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2024 revenue of $9.3-9.55 billion, versus the consensus of $8.971 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.